Footnotes
This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.
Conflict of interest: Dr. Jose has nothing to disclose.
Conflict of interest: Dr. King reports personal fees from Boehringer Ingelheim, outside the submitted work.
Conflict of interest: Dr. Shlobin has nothing to disclose.
Conflict of interest: Dr. Brown reports personal fees from Promedior , personal fees from Genentech, personal fees from PILOT for IPF, outside the submitted work.
Conflict of interest: SDN has been a consultant for the following Companies in the area of fibrotic lung disease and PH; Bayer Pharmaceuticals, Bellephoron, United Therapeutics, Actelion, and Third Pole.
Conflict of interest: Dr. Wang has nothing to disclose.
This is a PDF-only article. Please click on the PDF link above to read it.
- Copyright ©ERS 2018